Severe Asthma Spotlight-Pardon the Interruption 2022: Controversies in asthma

Video Transcription

Video Summary

In this video, a panel of experts discusses various topics related to severe asthma. The panelists discuss the best biologic for severe asthma, determining the effectiveness of a biologic, when to consider a change in management, tapering other control medications when a patient is doing well on a biologic, measuring and modifying airway remodeling, the role of oscillometry in asthma diagnosis, the availability of budesonide formoterol over the counter, the use of macrolides in treating severe asthma, and more. The panelists express different viewpoints and engage in lively conversation throughout the discussion. They touch on questions such as the appropriate selection of biologics for patients with asthma and eosinophilia, the discontinuation of biologic therapy when symptoms improve but there is no objective improvement, the use of as-needed ICS for modol, and the potential role of azithromycin in asthma treatment. The experts emphasize the need for individualized treatment plans and a multidisciplinary approach to asthma care. They agree that there is still much to learn about asthma management and improving outcomes for patients.

Meta Tag

Category Allergy and Airway

Speaker Monica Kraft, MD, FCCP

Speaker Sandhya Khurana, MD, FCCP

Speaker David Schulman, MD, MPH, FCCP

Speaker Sumita Khatri, MD, MS, FCCP

Speaker Mario Castro, MD

Speaker Frances Eun-Hyung Lee, MD

Keywords

severe asthma

biologic

change in management

airway remodeling

oscillometry

macrolides

eosinophilia

as-needed ICS

individualized treatment plans